CD276 and neuroblastoma: For example, 8H9, a murine IgG1 anti–B7-H3 mAb, has been conjugated to I-131 and proved efficacious, as one component of a multiagent regimen, in the treatment of patients with neuroblastoma who experienced a central nervous system relapse (40).